DK0981340T3 - Farmaceutiske formuleringer i tør form til oral administration af en cyklisk kvaternær ammoniumforbindelse - Google Patents

Farmaceutiske formuleringer i tør form til oral administration af en cyklisk kvaternær ammoniumforbindelse

Info

Publication number
DK0981340T3
DK0981340T3 DK98909550T DK98909550T DK0981340T3 DK 0981340 T3 DK0981340 T3 DK 0981340T3 DK 98909550 T DK98909550 T DK 98909550T DK 98909550 T DK98909550 T DK 98909550T DK 0981340 T3 DK0981340 T3 DK 0981340T3
Authority
DK
Denmark
Prior art keywords
quaternary ammonium
oral administration
pharmaceutical formulations
ammonium compound
dry form
Prior art date
Application number
DK98909550T
Other languages
Danish (da)
English (en)
Inventor
Bernard Abramovici
Xavier Boulenc
Jean-Claude Gautier
Pol Vilain
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0981340T3 publication Critical patent/DK0981340T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98909550T 1997-02-17 1998-02-17 Farmaceutiske formuleringer i tør form til oral administration af en cyklisk kvaternær ammoniumforbindelse DK0981340T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701826A FR2759585B1 (fr) 1997-02-17 1997-02-17 Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique
PCT/FR1998/000299 WO1998035663A1 (fr) 1997-02-17 1998-02-17 Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique

Publications (1)

Publication Number Publication Date
DK0981340T3 true DK0981340T3 (da) 2002-03-25

Family

ID=9503805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98909550T DK0981340T3 (da) 1997-02-17 1998-02-17 Farmaceutiske formuleringer i tør form til oral administration af en cyklisk kvaternær ammoniumforbindelse

Country Status (19)

Country Link
US (1) US6303626B1 (ja)
EP (1) EP0981340B1 (ja)
JP (1) JP2001511796A (ja)
AR (1) AR011806A1 (ja)
AT (1) ATE210436T1 (ja)
AU (1) AU6405098A (ja)
BR (1) BR9807406A (ja)
CA (1) CA2281607A1 (ja)
CO (1) CO4920216A1 (ja)
DE (1) DE69802921T2 (ja)
DK (1) DK0981340T3 (ja)
ES (1) ES2172116T3 (ja)
FR (1) FR2759585B1 (ja)
HK (1) HK1023509A1 (ja)
HR (1) HRP980074A2 (ja)
NO (1) NO993927D0 (ja)
PT (1) PT981340E (ja)
WO (1) WO1998035663A1 (ja)
ZA (1) ZA981288B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
AU2004289221B2 (en) * 2003-11-04 2009-12-17 Supernus Pharmaceuticals, Inc Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
CN102188424B (zh) * 2011-03-23 2013-03-27 浙江理工大学 Sr140333的抗血癌作用
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US20140271633A1 (en) * 2013-03-14 2014-09-18 Abbvie Inc. Mammalian cell culture performance through surfactant supplementation of feed media
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5679693A (en) 1992-09-30 1997-10-21 Sanofi 1-azoniabicyclo 2.2.1!heptanes, method of preparing them and pharmaceutical compositions in which they are present
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717804B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717802B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant.
CN1067385C (zh) * 1994-08-25 2001-06-20 默里尔药物公司 用于治疗变应性疾病的新的取代的哌啶类化合物
FR2725900B1 (fr) 1994-10-21 1997-07-18 Sanofi Sa Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
FR2725986B1 (fr) 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2729951B1 (fr) * 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2729954B1 (fr) 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
AR011806A1 (es) 2000-09-13
WO1998035663A1 (fr) 1998-08-20
ZA981288B (en) 1998-08-26
CO4920216A1 (es) 2000-05-29
ES2172116T3 (es) 2002-09-16
PT981340E (pt) 2002-05-31
FR2759585A1 (fr) 1998-08-21
BR9807406A (pt) 2000-03-14
FR2759585B1 (fr) 1999-06-11
DE69802921T2 (de) 2002-08-29
DE69802921D1 (de) 2002-01-24
JP2001511796A (ja) 2001-08-14
CA2281607A1 (en) 1998-08-20
EP0981340A1 (fr) 2000-03-01
AU6405098A (en) 1998-09-08
NO993927L (no) 1999-08-16
ATE210436T1 (de) 2001-12-15
US6303626B1 (en) 2001-10-16
NO993927D0 (no) 1999-08-16
EP0981340B1 (fr) 2001-12-12
HK1023509A1 (en) 2000-09-15
HRP980074A2 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
DK0876131T3 (da) Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener
DK215887D0 (da) Farmaceutisk praeparat af omeprazol til oral ind- gift
FI963984A (fi) Uusi oraalinen farmaseuttinen annostelumuoto
DK1083902T3 (da) Nye galeniske præparatformer af meloxicam til oral administrering
DK1100474T5 (da) Todelt kapsel til optag af farmaceutiske tilberedninger til inhalatorer
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
DE69833464D1 (de) Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-PyrazoloÄ1,5-bÜPyridazin Derivate
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
DK0936913T4 (da) Oralt farmaceutisk præparat indeholdende ibandronat
NO986165D0 (no) Preparat inneholdende taxan-analog for parentral administrering
EE200200097A (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
IS5245A (is) Lyfjablanda úr ómeprasól
DK0981340T3 (da) Farmaceutiske formuleringer i tør form til oral administration af en cyklisk kvaternær ammoniumforbindelse
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
PT868911E (pt) Formulacoes de rapamicina para administracao oral
EE200200314A (et) Tsüklilised kvaternaarsed ammooniumiühendid
EE200200073A (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
DK0994697T3 (da) Rapamycinformuleringer til oral indgivelse
DK28795A (da) Insulinholdigt polymerpræparat til oral administrering af insulin
PT98532A (pt) Processo para a preparacao de formulacoes solidas para aplicacao oral contendo como ingrediente activo ifosfamida
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
NO20001749D0 (no) Fremstilling av asymmetriske sykliske ureaforbindelser via et monoacylert diaminintermediat
NO993928D0 (no) Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium
SE9904819L (sv) En ny farmaceutisk komposition